Skip to main content

Cellgenemedix

Diagnostic Products

CellGeneMedix works in three areas: cancer genomics and longevity genetic testing, which are research programs under development, and COVID-19 diagnostic kits manufactured by our partner, Cellgenemedix, Inc.

Research use only

Cancer genomics

Molecular assays that detect treatment-guiding mutations quickly and at low cost.

KRAS / BRAF real-time PCR

Five-color multiplex real-time PCR using ARMS primers and probes. Reports KRAS status and BRAF (V600E / V600K) status in colorectal cancer in about four hours on CFX96 and ABI 7500 instruments.

Best Clinical Poster, ASCP 2024 Annual Meeting.

Breast cancer sequencing libraries

Library workflows for breast cancer gene panels on Illumina short-read and Oxford Nanopore long-read platforms, compared on the same samples.

In development

Cancer Genomics Research
Research use onlyIn development

Longevity genetic testing

Testing for healthy adults, so that screening and prevention can start earlier.

Inherited risk

Genetic risk for the major diseases of aging: cancer, cardiovascular disease, brain and nervous system, liver disease and kidney disease.

Biological aging markers

Blood-based markers linked to the hallmarks of aging, such as telomere length, DNA methylation “epigenetic clocks” and inflammation.

Longevity Genetic Testing
Not available in the U.S.2020–2022 products

COVID-19 diagnostic kits

Developed during the COVID-19 pandemic and manufactured by Goodgene, Inc. in Korea.

Not authorized or cleared by the U.S. FDA. These kits are not available for clinical use in the United States. Regulatory status outside the U.S. varies by product and country. See Certifications.
Product
What it does
Method
What it doesDetects SARS-CoV-2 nucleocapsid antigen in about 15–20 minutes without additional instruments
MethodLateral-flow rapid antigen test
What it doesDetects SARS-CoV-2 RNA. Over 95% sensitivity and specificity, about one hour run time, up to 95 specimens per run
MethodMultiplex real-time RT-PCR
What it doesDetects SARS-CoV-2 and distinguishes the Omicron and Delta variants
MethodQuadplex real-time RT-PCR
GG COVID-19 I-plex Real-Time PCR
What it doesDetects influenza A, influenza B and SARS-CoV-2 in one test
MethodQuadplex real-time RT-PCR

For laboratories: PCR kit workflow

Specimens: nasal, oral and oropharyngeal swabs; bronchoalveolar lavage; nasopharyngeal or oropharyngeal lavage or aspiration.

Steps: RNA extraction (for example, QIAamp Viral RNA Mini Kit), mixing GG reagents with RT-PCR master mix, then real-time PCR on Applied Biosystems 7500, CFX96 Touch, Rotor-Gene Q or LineGene 9600 Plus.

For product information or research collaborations, contact us.

Cancer genomics and longevity assays are for research use only, not for diagnostic use, and are not cleared or approved by the U.S. FDA.